ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB150

Removal of Middle Molecules with Hemodiafiltration plus Hemoadsorption in Patients with Kidney Failure

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Reis, Thiago A., Fenix Nephrology, São Paulo, SP, Brazil
  • Biluca, Bruno Piubelli, Fenix Nephrology, São Paulo, SP, Brazil
  • Guimaraes, Maria Gabriela, Nephrology Department, Hospital Ana Nery, Salvador, Brazil
  • Andrade, Jessica Liara Felicio de, Fenix Nephrology, São Paulo, Brazil
  • Goes, Miguel Angelo, Discipline of Nephrology, Federal University of São Paulo, São Paulo, Brazil
  • Watanabe, Andreia, Department of Pediatrics, Pediatric Nephrology Unit, Instituto da Criança e do Adolescente, University of São Paulo School of Medicine, São Paulo, Brazil
  • Ramirez Guerrero, Gonzalo, International Renal Research Institute of Vicenza, Vicenza, Italy
  • Ronco, Claudio, International Renal Research Institute of Vicenza, Vicenza, Italy
  • Neves, Francisco R., Laboratory of Molecular Pharmacology, University of Brasília, Brasília, DF, Brazil
  • Almeida, Antônio Luiz Junqueira de, Fenix Nephrology, São Paulo, SP, Brazil
Background

Hemodiafiltration (HDF) promotes a higher clearance of middle molecules compared to hemodialysis for patients with kidney failure. Whether the association of HDF plus hemoadsorption (Fig. 1a) using cartridges with styrene-divinylbenzene resin further enhances the removal of middle molecules is yet to be defined. We prospectively analyzed the removal of middle molecules in four patients undergoing simultaneous hemoadsorption in series with HDF.

Methods

Patients underwent 3-hour sessions of online HDF with post-filter replacement plus hemoadsorption. We measured the pre- and post-session concentrations of five middle molecules and albumin.

Results

Four patients performed a total of 23 sessions. Dialysis characteristics are presented in Table 1. In the sum of the 23 session, blood flow was 400 mL/min (IQR 350-400 mL/min), convective post-filter flow was 115 mL/min (IQR 105-115 mL/min), and dialysate flow was 500 mL/min (IQR 500-800 mL/min). The reduction ratio [i.e.,1 - (pre-session/post-session)] of parathormone (9.4 kDa), ß2-microglobulin (12 kDa), myoglobin (17 kDa), Prolactin (25 kDa), and lipase (33 kDa) are depicted in (Fig. 1b). There was a statistically significant increase in albumin (66 kDa) concentration between pre- and post-session (38.3 vs 40.0 g/L, p = 0.002).

Conclusion

Compared to previous results in HDF trials, where patients carried out 4-hour HDF stand-alone sessions, 3-hour HDF plus hemoadsorption sessions provide an equivalent or superior reduction ratio of five middle molecules.

Hemodiafiltration prescription
PatientsNumber of sessionsBlood flow (mL/min)Dialysate flow (mL/min)Post-filter replacement flow (mL/min)Vascular AccessFilter type/area
Patient 18350500115AVF - 15 GFx CorDiax 1000/2.3 m2
Patient 25400600115AVF - 15 GFx CorDiax 1000/2.3 m2
Patient 36400800105AVF - 15 GFx CorDiax 1000/2.3 m2
Patient 45420500115Tunnelled 14 FrFx CorDiax 1000/2.3 m2